The voltage-gated sodium channels (Nav) subtype Nav1.7 has been genetically validated to be involved in nociception. Join this free webinar to discover how engineering peptides achieves subtype specificity and complete inhibition of specific sodium channels to unlock the potential of potent venom peptides as therapeutic leads for the treatment of pain
Topics in this presentation include:
- Peptide inhibitors derived from venomous toxins
- The mechanism of action behind venom peptide inhibition of voltage-gated sodium channels
- How engineering peptides achieves subtype specificity and complete inhibition of specific sodium channels
Speaker
Christina I. Schroeder,
Stadtman Investigator
National Cancer Institute, National Institutes of Health
RSS 피드